Andreas Halvorsen
Add $103.2M of disclosed value in Pharvaris N.V. $PHVS.
Add
GLP-1 & Metabolic Health
Last updated
Jun 25, 2026
Based on
218 actions
Gurus considered
145
Stocks covered
170
Obesity, diabetes, GLP-1, and metabolic disease exposure. This page tracks 218 investor, Congress, and insider actions tied to GLP-1 & Metabolic Health within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 145 gurus across 170 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.
GLP-1 & Metabolic Health Smart Money Notes
Jim Simons
Trim $66.0M of disclosed value in Eli Lilly and Company Common Stock $LLY.
Trim
Sands Capital
Exit $-301.6M of disclosed value in iRhythm Technologies, Inc. $IRTC.
Exit
Tweedy Browne
Add $10.9M of disclosed value in Novartis AG Common Stock $NVS.
Add
Tom Gayner
Trim $105.5M of disclosed value in Novo Nordisk A/S $NVO.
Trim
Ken Fisher
Add $2.1B of disclosed value in Novartis AG Common Stock $NVS.
Add
Jefferies Group
Add $28.7M of disclosed value in PTC THERAPEUTICS, INC. $PTCT.
Add
Mario Gabelli
Add $7.7M of disclosed value in Eli Lilly and Company Common Stock $LLY.
Add
Showing 211-218 of 218